2021年第2四半期に,フィエラキャピタルコーポレーションはIDEXX Laboratoriesの株式を8000万ドル相当の164,309株に増えた. In Q2 2021, Fiera Capital Corp increased its stake in IDEXX Laboratories to 164,309 shares, worth $80 million.

Fiera Capital Corpは2021年第2四半期にIDEXX Laboratories (NASDAQ:IDXX) の株式を1億64,309株に増資し,その価値は8000万ドルとなった. Fiera Capital Corp raised its stake in IDEXX Laboratories (NASDAQ:IDXX) to 164,309 shares, valued at $80 million, during Q2 2021. 他の投資者も持株を調整し,IDEXXは"中程度の買い"のコンセンサス評価と582.25ドルの目標価格を受賞した. Other investors also adjusted their holdings, with IDEXX receiving a "Moderate Buy" consensus rating and a target price of $582.25. 同社は,推定額を欠いたQ3の1株当たり2.44ドルの利益を報告したが,その収益は6.4%増加して10億ドルとなった. The company reported Q3 earnings of $2.44 per share, missing estimates, but its revenue increased 6.4% to $1 billion. IDEXXは,獣医学,家畜,水検査市場向け製品に特化しています. IDEXX specializes in products for veterinary, livestock, and water testing markets.